Concepedia

Author

Liqian Su

Sun Yat-sen UniversityORCID

Also Known As

Liqian Su

12

Publications

206

Citations

8

H-Index

5

Concepts

All Affiliations

Sun Yat-sen UniversityNational Institutes for Food and Drug ControlShenzhen Second People's HospitalGuangdong Pharmaceutical UniversityHarbin Medical University
LS

About

Liqian Su is an author at Sun Yat-sen University specializing in oxidative stress, nanomedicine, and biomolecular engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

30

2

Biochemistry

1

1

30

3

Biomolecular Engineering

1

1

30

4

Oxidative Stress

1

1

30

5

Nanomedicine

1

1

30

Liqian Su

×

7

Publications

190

Citations

7

H-Index

YearCitations

Colon tissue-accumulating mesoporous carbon nanoparticles loaded with <i>Musca domestica</i> cecropin for ulcerative colitis therapy

Lun Zhang, Shuiqing Gui, Yinghua Xu,

Theranostics

2021

40

Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress

Jian Wang, Liqian Su, Lun Zhang,

Journal of Zhejiang University SCIENCE B

2022

40

Tumor-Infiltrating Cytotoxic T Cells and Tumor-Associated Macrophages Correlate With the Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Yuqin Yang, Wenjing Tian, Liqian Su,

Frontiers in Oncology

2021

38

Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment

Jian Wang, Lun Zhang, Hui Xin,

Acta Biomaterialia

2022

30

Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice

Manqi Zhang, Xichao Xu, Liqian Su,

Journal of Nanobiotechnology

2024

18

Vimentin and tumor–stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer

Wenjing Tian, Yuqin Yang, Qi Qin,

Cancer Science

2022

14

PD-L1 antibody-modified plant-derived nanovesicles carrying a STING agonist for the combinational immunotherapy of melanoma

Zhanxue Xu, Xinrui Yang, Xingyu Lu,

Biomaterials

2025

10

Page 1